We urge consumers to beware of these and other unproven drug products that use deceptive marketing tactics to sell their unsafe products. The order prohibits Flawless Beauty and its owners from importing, manufacturing or distributing any products until they comply with federal regulations
The 5% Problem: The Access Gap Behind GLP-1s, Hormone Therapy, and Midlife Weight Gain What the science actually shows about menopause, metabolism, and GLP-1s - and why the biggest barrier isnt biology, but access to evidence-based care
We follow strict quality checks at every stage of production
Request contract samples with clear definitions of success, such as weight loss thresholds, A1C reductions, and deprescription rates, as well as transparent claims-based performance validation
With key GLP-1 drug patents expected to expire around March 2026, Indian pharmaceutical companies are preparing to launch lower-cost alternatives in one of the fastest-growing therapeutic markets
the stack outcomes are not well proven